Page last updated: 2024-11-03

proglumide and Cancer of Intestines

proglumide has been researched along with Cancer of Intestines in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bershteĭn, LM1
Zabezhinskiĭ, MA1
Stukov, AN1
Kalikhevich, VN1
Mikheev, AM1

Other Studies

1 other study available for proglumide and Cancer of Intestines

ArticleYear
[The hormonal sensitivity of a transplantable adenocarcinoma of the large intestine].
    Eksperimental'naia onkologiia, 1990, Volume: 12, Issue:5

    Topics: Adenocarcinoma; Adenylyl Cyclases; Animals; Cell Line; Drug Resistance; Drug Screening Assays, Antit

1990